Related Experiment Video
Updated: Mar 28, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Irritable Bowel Syndrome: A Clinical Review
Michael D Cashman1, Daniel K Martin, Sonu Dhillon
1Clinical Professor of Internal Medicine, University of Illinois College of Medicine at Peoria, 5105 Glen Park Place, Peoria, IL 61614, USA. Michael.D.Cashman@osfhealthcare.org.
Irritable bowel syndrome (IBS) involves complex brain-gut interactions, with central sensitization potentially linking symptoms to life experiences. Effective IBS management requires recognizing symptom clusters and prioritizing the patient-provider relationship.
Area of Science:
- Gastroenterology
- Neuroscience
- Psychology
Background:
- Irritable bowel syndrome (IBS) presents with chronic abdominal pain and altered bowel habits, often accompanied by other symptoms.
- The pathophysiology of IBS is complex, involving disturbances in the brain-gut axis, including psychosocial factors, immune responses, and the microbiome.
- Heterogeneous patient presentations complicate generalizations about IBS.
Purpose of the Study:
- To explore the underlying mechanisms of IBS, focusing on the brain-gut axis and central sensitization.
- To conceptualize IBS within a biopsychosocial framework for diagnosis and treatment.
- To highlight the importance of a positive diagnostic approach and the physician-patient relationship in managing IBS.
Main Methods:
- Review of current understanding of IBS pathophysiology, including central mechanisms like the stress response and neuroendocrine factors.
- Exploration of the concept of Central Sensitization (CS) as a unifying framework for IBS.
- Discussion of diagnostic strategies and the role of psychosocial factors in patient presentation and management.
Main Results:
- IBS pathophysiology involves the brain-gut axis, with central mechanisms playing a significant role.
- Central Sensitization (CS) offers a model to integrate life experiences and psychological responses into IBS pathophysiology.
- Visceral hypersensitivity in IBS may share mechanisms with other pain syndromes like fibromyalgia (FMS).
Conclusions:
- A biopsychosocial framework, incorporating Central Sensitization, is valuable for understanding and treating IBS.
- Recognizing symptom clusters and "alarm" symptoms is crucial for a positive diagnostic approach.
- Multidisciplinary management and a strong physician-patient relationship are essential for effective long-term IBS care.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

